Results 21 to 30 of about 81,765 (240)
Circulation, 1998 To the Editor: In a recent issue of Circulation , Brown and Vaughan1 reviewed ACE inhibitors. They stated that captopril and lisinopril are active drugs and listed 7 other ACE inhibitors approved in the United States that are inactive prodrugs until metabolized in the liver.
openaire +2 more sources
Рациональная фармакотерапия в кардиологии, 2016 The main trails proven angiotensin converting enzyme (ACE) inhibitor effects on the life prognosis after myocardial infarction (MI) are described. Different tactics of ACE inhibitors therapy in post MI patients are presented.
S. Yu. Martsevich
doaj +1 more source
ACE as a mechanosensor to shear stress influences the control of its own regulation via phosphorylation of cytoplasmic Ser(1270). [PDF]
PLoS ONE, 2011 OBJECTIVES: We tested whether angiotensin converting enzyme (ACE) and phosphorylation of Ser(1270) are involved in shear-stress (SS)-induced downregulation of the enzyme.
Valerio Garrone Barauna +3 more
doaj +1 more source
Captopril-Associated Cough Is Not due to Increased Airway Responsiveness
Canadian Respiratory Journal, 1994 BACKGROUND: Angiotensin-converting enzyme (ACE) inhibitors commonly cause cough. There is controversy as to whether preexisting airway hyperresponsivencss predisposes patients to ACE inhibitor-induced cough and whether ACE inhibitor therapy can cause ...
SP Blackie +4 more
doaj +1 more source
PLoS Medicine, 2016 BackgroundMedications aimed at inhibiting the renin-angiotensin system (RAS) have been used extensively for preventing cardiovascular and renal complications in patients with diabetes, but data that compare their clinical effectiveness are limited.
Ferrán Catalá-López +11 more
doaj +1 more source
Effect of angiotensin converting enzyme inhibitor and angiotensin II receptor blocker on the patients with sepsis [PDF]
The Korean Journal of Internal Medicine, 2021 Background/Aims Inhibitors of the renin-angiotensin system, angiotensin-converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARBs), reportedly have anti-inflammatory effects.
Hyun Woo Lee +3 more
doaj +1 more source
Kidney & Blood Pressure Research, 2013 Background: Treating non-diabetic proteinuric patients with advanced renal disease with an angiotensin-converting enzyme (ACE) inhibitor is still subject to discussion.
Charles Christian Adarkwah +3 more
doaj +1 more source
Dose response of ACE inhibitors: implications of the SECURE trial
Current Controlled Trials in Cardiovascular Medicine, 2001 The choice of the appropriate dosage of ACE inhibitor in clinical practice is an important one. The available evidence suggests that in chronic heart failure as well as in chronic coronary artery disease, high doses of angiotensin-converting enzyme (ACE)
Lonn Eva
doaj +1 more source
Effect of angiotensin‐converting enzyme inhibition on cardiovascular adaptation to exercise training
Physiological Reports, 2022 Angiotensin‐converting enzyme (ACE) activity may be one determinant of adaptability to exercise training, but well‐controlled studies in humans without confounding conditions are lacking.
Tórur Sjúrðarson +13 more
doaj +1 more source
Therapeutic approaches to slowing the progression of diabetic nephropathy – is less best?
Drugs in Context, 2013 Objective: Angiotensin II receptor blockers (ARBs) and angiotensin-converting enzyme (ACE) inhibitors are known to reduce proteinuria and have been the first-line agents in the management of diabetic nephropathy for the past 20 years.
Eva Vivian, Chelsea Mannebach
doaj +1 more source